Literatur
- 1
Adam R, Pascal G, Castaing D. et al .
Tumor progression while on chemotherapy: a contraindication to liver resection for
multiple colorectal metastases?.
Ann Surg.
2004;
240
1052-1061
- 2
Andre N, Schmiegel W.
Chemoradiotherapy for colorectal cancer.
Gut.
2005;
54
1194-1202
- 3
Bujko K, Nowacki M P, Nasierowska-Guttmejer A. et al .
Sphincter preservation following preoperative radiotherapy for rectal cancer: report
of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated
radiochemotherapy.
Radiother Oncol.
2004;
72
15-24
- 4
Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M.
Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.
JAMA.
2000;
284
1008-1015
- 5
Colorectal Cancer Collaborative Group .
Surgery for colorectal cancer in elderly patients: a systematic review.
Lancet.
2000;
356
968-974
- 6
Cunningham D, Humblet Y, Siena S. et al .
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic
colorectal cancer.
N Engl J Med.
2004;
351
337-345
- 7
de Gramont A, Figer A, Seymour M. et al .
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in
advanced colorectal cancer.
J Clin Oncol.
2000;
18
2938-2947
- 8
Douillard J Y, Cunningham D, Roth A D. et al .
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line
treatment for metastatic colorectal cancer: a multicentre randomised trial.
Lancet.
2000;
355
1041-1047
- 9
Fernandez F G, Ritter J, Goodwin J W, Linehan D C, Hawkins W G, Strasberg S M.
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on
resectability of hepatic colorectal metastases.
J Am Coll Surg.
2005;
200
845-853
- 10
Giacchetti S, Perpoint B, Zidani R. et al .
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin
as first-line treatment of metastatic colorectal cancer.
J Clin Oncol.
2000;
18
136-147
- 11
Goldberg R M, Sargent D J, Morton R F. et al .
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin
combinations in patients with previously untreated metastatic colorectal cancer.
J Clin Oncol.
2004;
22
23-30
- 12
Grothey A, Sargent D, Goldberg R M, Schmoll H J.
Survival of patients with advanced colorectal cancer improves with the availability
of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.
J Clin Oncol.
2004;
22
1209-1214
- 13
Hurwitz H, Fehrenbacher L, Novotny W. et al .
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal
cancer.
N Engl J Med.
2004;
350
2335-2342
- 14
Kapiteijn E, Marijnen C A, Nagtegaal I D. et al. Dutch Colorectal Cancer Group .
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal
cancer.
N Engl J Med.
2001;
345
638-646
- 15
Kehoe J, Khatri V P.
Staging and prognosis of colon cancer.
Surg Oncol Clin N Am.
2006;
15
129-146
- 16
MacFarlane J K, Ryall R D, Heald R J.
Mesorectal excision for rectal cancer.
Lancet.
1993;
341
457-460
- 17
Saltz L B, Cox J V, Blanke C. et al .
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan
Study Group.
N Engl J Med.
2000;
343
905-914
- 18
Sauer R, Becker H, Hohenberger W. et al. German Rectal Cancer Study Group .
Preoperative versus postoperative chemoradiotherapy for rectal cancer.
N Engl J Med.
2004;
351
1731-1740
- 19
Schmiegel W, Pox C, Adler G. et al .
S3-Leitlinienkonferenz „Kolorektales Karzinom” 2004.
Z Gastroenterol.
2004;
42
1129-1177
- 20
Swedish Rectal Cancer Trial .
Improved survival with preoperative radiotherapy in resectable rectal cancer.
N Engl J Med.
1997;
336
980-987
- 21
Tournigand C, Andre T, Achille E. et al .
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:
a randomized GERCOR study.
J Clin Oncol.
2004;
22
229-237
- 22
Willis S, Schumpelick V.
Rekonstruktion nach Rektumresektion.
Chirurg.
2004;
75
13-20
Prof. Dr. med. Carsten Gartung
Klinikum Minden, Zentrum für Innere Medizin, Schwerpunkt Gastroenterologie, Hepatologie
und Infektionskrankheiten
Friedrichstr. 17
32427 Minden
Phone: 0571/8013001
Fax: 0571/8013004
Email: carsten.gartung@klinikum-minden.de
